Pirfenidone reduces in vitro rat renal fibroblast activation and mitogenesis.
about
Drug Eluting Stents for Malignant Airway Obstruction: A Critical Review of the LiteraturePirfenidone nanoparticles improve corneal wound healing and prevent scarring following alkali burnImproved mitochondrial function underlies the protective effect of pirfenidone against tubulointerstitial fibrosis in 5/6 nephrectomized ratsIn vitro effects of pirfenidone on cardiac fibroblasts: proliferation, myofibroblast differentiation, migration and cytokine secretion.Pirfenidone inhibits TGF-β1-induced over-expression of collagen type I and heat shock protein 47 in A549 cells.Development of second generation peptides modulating cellular adiponectin receptor responses.Anti-fibrotic action of pirfenidone in Dupuytren's disease-derived fibroblastsInhibition of pirfenidone on TGF-beta2 induced proliferation, migration and epithlial-mesenchymal transition of human lens epithelial cells line SRA01/04The multifaceted role of pirfenidone and its novel targets.Pirfenidone: an anti-fibrotic therapy for progressive kidney disease.Novel therapeutic approaches for pulmonary fibrosis.Therapeutic potential of Pirfenidone for treating equine corneal scarringPharmacokinetics of pirfenidone after topical administration in rabbit eye.Pirfenidone inhibits transforming growth factor-β1-induced fibrogenesis by blocking nuclear translocation of Smads in human retinal pigment epithelial cell line ARPE-19.Suppression of TGF-β pathway by pirfenidone decreases extracellular matrix deposition in ocular fibroblasts in vitroPhenylpyrrolidine structural mimics of pirfenidone lacking antifibrotic activity: A new tool for mechanism of action studies.Pirfenidone inhibits fibrosis in foreign body reaction after glaucoma drainage device implantationPirfenidone is renoprotective in diabetic kidney disease.Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.Resolution of inflammation: therapeutic potential of pro-resolving lipids in type 2 diabetes mellitus and associated renal complications.Explanting is an ex vivo model of renal epithelial-mesenchymal transition.Combined Effects of Drugs and Plasticizers on the Properties of Drug Delivery Films.Sequential Release of Multiple Drugs from Flexible Drug Delivery Films.The fibrotic tumor stroma.Pirfenidone inhibits post-traumatic proliferative vitreoretinopathy.Pirfenidone suppresses TGF‑β1‑induced human intestinal fibroblasts activities by regulating proliferation and apoptosis via the inhibition of the Smad and PI3K/AKT signaling pathway
P2860
Q26766244-5ECDA9A5-9E8A-4D2D-96B0-CAED8E0D6ED9Q28535107-488DCBFD-C2C3-41FF-BF12-228B12FDE70CQ28536610-413D6E1B-DC1F-4673-B52F-A657E438D6DEQ34088175-B05C188E-9040-4DE6-9EFF-94C964CDA28CQ34303074-52026BA3-8CD9-4105-8C76-7B12207BD148Q34360125-D4707D80-896D-42E5-B95D-4A4EE72562C2Q34544470-D384B411-96F6-4E5E-BA74-AB6B9B1A7C18Q34599567-E91FC6A3-1699-4B3B-A111-65460FD09920Q34623073-CC32FE0D-8891-414F-BDB1-D971E029E0A0Q34680788-48C5BC75-69A1-4585-8A75-6514A90BF337Q34903224-10E22784-2A7D-402F-B70A-1E871516E556Q34964866-673A62E3-3BB9-4279-B75B-71311ACEF713Q35175331-00F3692B-54C9-4EDA-91CC-1B6362BA6F20Q35919077-42D0FA7D-236B-4CD1-B5C5-40E7F054295BQ36288420-66951482-CBF2-438D-8E57-FE319058B284Q36391459-40FEEE12-28B5-4506-91B2-6D5DF73DEE45Q36826817-D319A339-E99B-4C22-B1C8-EE229071A0CBQ37297659-4513850F-7580-4AD8-A9B0-C37495C2F032Q37686160-47AB6ADE-DC85-431E-9E8D-122935B671B3Q38054089-8F1772D2-ECB1-4E8F-B120-33F266C6C62CQ39488790-AE0E81D1-6F03-4989-8F0E-B2B3713E36F8Q41679100-1A49999D-D766-4CA7-9880-F814D6D06581Q47120996-8D659A4D-BB84-4D80-825A-EEFAB7CB9251Q47205727-DBCF1895-8B85-4A65-AFB9-BAC1644E7CEFQ50792998-0ACBB766-4C40-4D5C-9084-57097153BE20Q58718304-09CEF4D5-1EAF-4DA4-B53A-201AE9FACD4E
P2860
Pirfenidone reduces in vitro rat renal fibroblast activation and mitogenesis.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Pirfenidone reduces in vitro rat renal fibroblast activation and mitogenesis.
@ast
Pirfenidone reduces in vitro rat renal fibroblast activation and mitogenesis.
@en
Pirfenidone reduces in vitro rat renal fibroblast activation and mitogenesis.
@nl
type
label
Pirfenidone reduces in vitro rat renal fibroblast activation and mitogenesis.
@ast
Pirfenidone reduces in vitro rat renal fibroblast activation and mitogenesis.
@en
Pirfenidone reduces in vitro rat renal fibroblast activation and mitogenesis.
@nl
prefLabel
Pirfenidone reduces in vitro rat renal fibroblast activation and mitogenesis.
@ast
Pirfenidone reduces in vitro rat renal fibroblast activation and mitogenesis.
@en
Pirfenidone reduces in vitro rat renal fibroblast activation and mitogenesis.
@nl
P2093
P1476
Pirfenidone reduces in vitro rat renal fibroblast activation and mitogenesis
@en
P2093
P304
P50
P577
2001-11-01T00:00:00Z